ZUSDURI drives office-based NMIBC care, rapid revenue growth, and a de-risked pipeline. Click here to read more on URGN stock ...
A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most ...
Researchers have found that, with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use ...
Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use ...
Advances in the treatment of hematologic malignancies, including leukemias, lymphomas and myeloproliferative neoplasms, have extended survival and, in many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results